• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活质量的下降与α-1抗胰蛋白酶缺乏症患者的病情加重频率相关——来自德国登记处的分析。

Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.

作者信息

Bernhard Nikolas, Lepper Philipp M, Vogelmeier Claus, Seibert Martina, Wagenpfeil Stefan, Bals Robert, Fähndrich Sebastian

机构信息

Department of Internal Medicine V - Pulmonology, Allergology, Intensive Care Medicine, Saarland University Hospital, Homburg.

Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Member of the German Center for Lung Research (DZL).

出版信息

Int J Chron Obstruct Pulmon Dis. 2017 May 12;12:1427-1437. doi: 10.2147/COPD.S130925. eCollection 2017.

DOI:10.2147/COPD.S130925
PMID:28553095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5439990/
Abstract

BACKGROUND

Alpha-1-antitrypsin deficiency (AATD) is a rare hereditary disease that is associated with a higher risk to develop chronic obstructive pulmonary disease and liver cirrhosis. Previous cross-sectional studies on AATD individuals have shown a relationship between worse St George's Respiratory Questionnaire (SGRQ) scores and elevated exacerbation rate or high cigarette consumption. There is a lack of longitudinal data on the relationship between the exacerbation rate and worsening of SGRQ during disease. The aim of this study was to provide not only cross-sectional data but also information about the deterioration in quality of life over a follow-up period up to 7 years (median follow-up period of 3.33 years).

METHODS

We investigated questionnaire-based data of the German AATD registry concerning the relationship between SGRQ and exacerbation frequency, smoking history, forced expiratory volume in 1 second (FEV) and carbon monoxide diffusion capacity (DLCO) first in cross-sectional analysis and later in longitudinal analysis.

RESULTS

Eight hundred sixty-eight individuals with protease inhibitor ZZ (PiZZ) genotype with an average age of 52.6±12.8 years had an SGRQ score of 45.7±20.6. SGRQ significantly correlated with the exacerbation frequency within the last 2 years (=0.464; <0.001), smoking history (=0.233; <0.001), FEV (=-0.436; <0.001), DLCO (=-0.333; <0.001), and patients' age (=0.292; <0.001). Individuals with occupational dust exposure had significantly worse quality of life (<0.001). Mean annual deterioration of SGRQ in all patients with available follow-up data (n=286) was 1.21±4.45 points per year. Univariate and multivariate analysis showed a significant relationship between worsening of SGRQ/year and exacerbation frequency in the follow-up period (=0.144; =0.015).

CONCLUSION

Worsening of SGRQ is associated with the exacerbation frequency in individuals with PiZZ AATD.

摘要

背景

α-1抗胰蛋白酶缺乏症(AATD)是一种罕见的遗传性疾病,与患慢性阻塞性肺疾病和肝硬化的较高风险相关。先前针对AATD患者的横断面研究表明,圣乔治呼吸问卷(SGRQ)得分较差与加重率升高或高吸烟量之间存在关联。目前缺乏关于疾病期间加重率与SGRQ恶化之间关系的纵向数据。本研究的目的不仅是提供横断面数据,还提供长达7年(中位随访期3.33年)的随访期内生活质量恶化的信息。

方法

我们首先在横断面分析中,然后在纵向分析中,调查了德国AATD登记处基于问卷的数据,这些数据涉及SGRQ与加重频率、吸烟史、第1秒用力呼气量(FEV)和一氧化碳弥散量(DLCO)之间的关系。

结果

868名蛋白酶抑制剂ZZ(PiZZ)基因型个体,平均年龄52.6±12.8岁,SGRQ评分为45.7±20.6。SGRQ与过去2年内的加重频率(=0.464;<0.001)、吸烟史(=0.233;<0.001)、FEV(=-0.436;<0.001)、DLCO(=-0.333;<0.001)以及患者年龄(=0.292;<0.001)显著相关。有职业性粉尘暴露的个体生活质量明显较差(<0.001)。所有有可用随访数据的患者(n=286)中,SGRQ的平均每年恶化程度为每年1.21±4.45分。单因素和多因素分析显示,随访期内SGRQ/年的恶化与加重频率之间存在显著关系(=0.144;=0.015)。

结论

PiZZ AATD个体中SGRQ的恶化与加重频率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/1044536491a5/copd-12-1427Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/dbe26bdf2cfd/copd-12-1427Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/2c00aee15042/copd-12-1427Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/eb37893f1556/copd-12-1427Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/1044536491a5/copd-12-1427Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/dbe26bdf2cfd/copd-12-1427Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/2c00aee15042/copd-12-1427Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/eb37893f1556/copd-12-1427Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6525/5439990/1044536491a5/copd-12-1427Fig4.jpg

相似文献

1
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.生活质量的下降与α-1抗胰蛋白酶缺乏症患者的病情加重频率相关——来自德国登记处的分析。
Int J Chron Obstruct Pulmon Dis. 2017 May 12;12:1427-1437. doi: 10.2147/COPD.S130925. eCollection 2017.
2
Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV in individuals with PiZZ alpha-1-antitrypsin deficiency.对于PiZZ型α-1抗胰蛋白酶缺乏症患者,病情加重和戒烟时长与每年的第一秒用力呼气容积(FEV)损失相关。
Respir Med. 2017 Aug;129:8-15. doi: 10.1016/j.rmed.2017.05.011. Epub 2017 May 24.
3
Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.重度吸烟会缩小α-1-抗胰蛋白酶缺乏症基因型 PiZZ 和 PiSZ 之间生活质量和恶化频率的差异。
Respir Med. 2017 Sep;130:1-8. doi: 10.1016/j.rmed.2017.07.004. Epub 2017 Jul 8.
4
Decline in FEV and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency.严重的α-1 抗胰蛋白酶缺乏症个体的 FEV 下降和住院加重。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1075-1083. doi: 10.2147/COPD.S195847. eCollection 2019.
5
Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience.α-1抗胰蛋白酶缺乏症患者的健康相关生活质量:法国的经验。
COPD. 2015 May;12 Suppl 1:46-51. doi: 10.3109/15412555.2015.1022645.
6
Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).来自西班牙注册研究(REDAAT)的α-1抗胰蛋白酶缺乏症患者肺功能的长期演变
Int J Chron Obstruct Pulmon Dis. 2018 Mar 23;13:1001-1007. doi: 10.2147/COPD.S155226. eCollection 2018.
7
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.通过新生儿筛查确定的瑞典α1-抗胰蛋白酶缺乏队列在37至40岁时的健康状况和肺功能。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 2;12:495-500. doi: 10.2147/COPD.S120241. eCollection 2017.
8
Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease.α1抗胰蛋白酶缺乏相关肺部疾病患者队列中圣乔治呼吸问卷(SGRQ)的长期稳定性
Int J Chron Obstruct Pulmon Dis. 2024 Apr 10;19:889-900. doi: 10.2147/COPD.S443183. eCollection 2024.
9
Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?α-1 抗胰蛋白酶缺乏症的健康状况下降:疾病修正疗法的可行结果?
Respir Res. 2018 Jul 20;19(1):137. doi: 10.1186/s12931-018-0844-6.
10
Maximal mid-expiratory flow detects early lung disease in α-antitrypsin deficiency.最大呼气中期流量可检测α-抗胰蛋白酶缺乏症的早期肺疾病。
Eur Respir J. 2017 Mar 29;49(3). doi: 10.1183/13993003.02055-2016. Print 2017 Mar.

引用本文的文献

1
Is It Time Alpha-1 Antitrypsin Deficiency Had a Specific Patient Reported Outcome Measure? A Review.α-1抗胰蛋白酶缺乏症是否到了拥有特定患者报告结局指标的时候?一项综述。
Patient Relat Outcome Meas. 2025 Jan 15;16:23-35. doi: 10.2147/PROM.S490849. eCollection 2025.
2
Influencing factors of good quality of life among chronic obstructive pulmonary disease patients living in Zhejiang Province, China.中国浙江省慢性阻塞性肺疾病患者生活质量良好的影响因素。
Sci Rep. 2024 Apr 15;14(1):8687. doi: 10.1038/s41598-024-59289-9.
3
Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysis.

本文引用的文献

1
Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry.α-1抗胰蛋白酶缺乏症所致肺病的性别差异——来自德国登记处的分析
COPD. 2015 May;12 Suppl 1:58-62. doi: 10.3109/15412555.2015.1023785.
2
Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience.α-1抗胰蛋白酶缺乏症患者的健康相关生活质量:法国的经验。
COPD. 2015 May;12 Suppl 1:46-51. doi: 10.3109/15412555.2015.1022645.
3
Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management.
与 SF-36 相关的特征在 α-1 抗胰蛋白酶缺乏相关 COPD 中的表现:一项横断面分析。
BMC Pulm Med. 2024 Mar 18;24(1):138. doi: 10.1186/s12890-024-02953-7.
4
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.与α-1 抗胰蛋白酶缺乏症相关的疾病负担:系统和结构化文献回顾。
Eur Respir Rev. 2022 Mar 23;31(163). doi: 10.1183/16000617.0262-2021. Print 2022 Mar 31.
5
Exacerbations of Lung Disease in Alpha-1 Antitrypsin Deficiency.α-1抗胰蛋白酶缺乏症所致的肺部疾病急性加重
Chronic Obstr Pulm Dis. 2021 Jan;8(1):162-76. doi: 10.15326/jcopdf.2020.0173.
6
Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors.为何α-1抗胰蛋白酶缺乏症的疾病穿透率如此多变?环境因素的作用
Chronic Obstr Pulm Dis. 2020 Jul;7(3):280-289. doi: 10.15326/jcopdf.7.3.2019.0177.
7
Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?α-1 抗胰蛋白酶缺乏症的健康状况下降:疾病修正疗法的可行结果?
Respir Res. 2018 Jul 20;19(1):137. doi: 10.1186/s12931-018-0844-6.
加拿大的α-1抗胰蛋白酶缺乏症:诊断与管理中的地区差异
COPD. 2015 May;12 Suppl 1:15-21. doi: 10.3109/15412555.2015.1021908.
4
Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者5年期间生活质量各组成部分的差异变化。
Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:745-57. doi: 10.2147/COPD.S77586. eCollection 2015.
5
A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges.慢性阻塞性肺疾病中最常见的患者报告结局综述——回顾现有知识并预估未来挑战。
Int J Chron Obstruct Pulmon Dis. 2015 Apr 7;10:725-38. doi: 10.2147/COPD.S77368. eCollection 2015.
6
One-year change in health status and subsequent outcomes in COPD.COPD 患者健康状况的一年变化及随后的结果。
Thorax. 2015 May;70(5):420-5. doi: 10.1136/thoraxjnl-2014-205697. Epub 2015 Mar 17.
7
Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.CAT、LCOPD、EQ-5D和COPDSS量表在理解α-1抗胰蛋白酶缺乏症患者肺部疾病影响方面的实用性。
COPD. 2014 Sep;11(5):480-8. doi: 10.3109/15412555.2014.898030. Epub 2014 May 15.
8
Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.职业性接触粉尘、气体和烟雾与瑞士成年人空气污染与肺部和心脏疾病队列研究中慢性阻塞性肺疾病的发病关系。
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1292-300. doi: 10.1164/rccm.201110-1917OC. Epub 2012 Apr 6.
9
Prognostic assessment in COPD: health related quality of life and the BODE index.COPD 的预后评估:健康相关生活质量和 BODE 指数。
Respir Med. 2011 Jun;105(6):916-21. doi: 10.1016/j.rmed.2011.01.007. Epub 2011 Feb 1.
10
The problems of clinical trials and registries in rare diseases.罕见病临床试验和注册研究中存在的问题。
Respir Med. 2010 Jul;104 Suppl 1:S42-4. doi: 10.1016/j.rmed.2010.03.016. Epub 2010 Apr 21.